Mode
Text Size
Log in / Sign up
Phase 2 N=258 Randomized Single-blind Treatment

The Anchor Study: Digitally Delivered Intervention for Reducing Problematic Substance Use

Alcohol Use Disorder (AUD) · Substance Use Disorders

Enrolled (actual)
258
Serious AEs
0.0%
Results posted
Oct 2024
Primary outcome: Primary: Change in Number of Substance Use Occasions — -11.3; -11.2; -13.6; -12.9 occasions

Study Design & Population

Study type
Interventional
Phase
Phase 2
Interventions
W-SUDs (Device); Digitally-delivered Psychoeducation (Other)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Woebot Health
Primary completion
Aug 2023

Outcome Measures

OutcomeResultp-value
PRIMARY
Change in Number of Substance Use Occasions
-11.3; -11.2; -13.6; -12.9; -15.7; -15.4
SECONDARY
Drug Abuse Screening Test (DAST-10)
-1.21; -1.95
SECONDARY
Working Alliance Inventory (WAI-SR)
14.8; 14.4; 15.2
SECONDARY
Stanford Presenteeism Scale (SPS-6)
-5.42; -4.12
SECONDARY
Thoughts About Abstinence (TAA): Desire to Quit, Expected Success at Quitting, Expected Difficulty of Quitting Items
0.21; 0.12; 0.42; 0.53; -0.64; -0.28
SECONDARY
Thoughts About Abstinence (TAA): Goal Item
10; 12; 25; 22; 14; 9
SECONDARY
Usage Rating Profile - Intervention (URPI)-Acceptability
30.1; 30.3
SECONDARY
Usage Rating Profile - Intervention (URPI)-Feasibility
28.0; 29.8
SECONDARY
Client Satisfaction Questionnaire (CSQ-8)
26.9; 28.1
SECONDARY
Short Inventory of Problems- Alcohol and Drugs (SIP-AD)
-8.02; -7.39; -9.02; -9.24; -11.5; -10.9
SECONDARY
Patient Health Questionnaire (PHQ-8)
-1.84; -1.44; -2.82; -2.05; -2.83; -2.87
SECONDARY
Generalized Anxiety Disorder (GAD-7)
-1.31; -1.56; -1.88; -1.72; -2.09; -2.57
SECONDARY
Brief Situational Confidence Questionnaire (BSCQ)
7.3; 10.4; 6.77; 11.6; 11.6; 15.6
SECONDARY
Craving Ratings
-0.418; -0.56; -0.66; -0.722; -0.816; -0.892
SECONDARY
Past Month Number of Binge Days
-4.26; -2.45; -4.09; -2.51; -5.43; -3.14
SECONDARY
Past Month Average Standard Drinks in a Week
-7.62; -6.92; -8.67; -8.18; -11.1; -9.43

Summary

This study aims to validate W-SUDs as a digitally-delivered substance use disorder program through a fully-powered randomized control trial that will test the comparative efficacy of the mobile-app based substance use disorder program (W-SUDs) to reduce substance use relative to a psychoeducation control condition, which has no cognitive behavioral therapy and the content is not delivered through a conversational user interface.

Eligibility Criteria

Inclusion Criteria

  • Have a smartphone
  • Endorse a substance use concern
  • Be between 18 and 65 years of age
  • Be available and committed to engage with the Woebot app
  • Be literate in English. (This is required for inclusion because all materials will be in English).

Exclusion Criteria

  • Pregnancy (as W-SUDs will not be specifically developed to address the unique needs of this population)
  • Suicide attempt within the past year (12 months)
  • Symptoms of severe drug/alcohol history: History of delirium tremens; Experiencing hypertension, drenching sweats, seizures or confusion after stopping alcohol or drugs; Liver trouble (cirrhosis or hepatitis); Convulsions or GI bleeding due to drug/alcohol use
  • Opioid overdose within the past year (12 months)
  • Opioid misuse without medication-assisted treatment
  • Not residing in the U.S.
  • Previous Woebot use
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04925570). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search